Compare Tango Therapeutics Inc. (TNGX) vs Trane Technologies plc (TT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tango Therapeutics Inc. vs Trane Technologies plc — how do they compare? Tango Therapeutics Inc. trades at $22.5 (market cap $3.74B), while Trane Technologies plc trades at $468.12 (market cap $103.69B). The key difference: Trane Technologies plc is far larger — about 27.7× Tango Therapeutics Inc.'s market cap, and Trane Technologies plc pays a 0.89% dividend while Tango Therapeutics Inc. pays none. Which is the better fit depends on your goals.
| TNGX | TT | |
|---|---|---|
Market Cap | $3.74B | $103.69B |
Volume | 3,438,781 | 922,354 |
Sector | Health | Industrials |
52-Week High | $32.90 | $503.46 |
52-Week Low | $7.50 | $376.43 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $2.76B | $106.99B |
Dividend Yield | — | 0.89% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TNGX trades at $22.22, down 8.07% in the last session, reflecting negative investor reaction to recent earnings misses. The stock shows neutral technical signals with key support at $21 and resistance at $23. Fundamentally, the company maintains a high gross margin of 98.25% but faces significant losses with a net income margin of -229.92% and negative cash flow from operations. Recent news highlights institutional buying interest and upcoming clinical trial developments.
Despite strong analyst support with a $45.91 consensus price target (107% upside), TNGX faces substantial execution risks as a clinical-stage biotech. The company's heavy cash burn and lack of profitability require careful monitoring of pipeline progress. Investment appeal hinges on successful drug development outcomes rather than current financial metrics.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tango Therapeutics Inc.
Tango Therapeutics, Inc. is a clinical-stage biotechnology company focused on precision oncology, developing cancer therapies based on the genetic principle of synthetic lethality, including its PRMT5 inhibitor program.
Read more on TNGX →About Trane Technologies plc
Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →
